FDA Inspection 578223 — Cargille-Sacher Laboratories Inc.

Cargille-Sacher Laboratories Inc. — FEI 2210661

The FDA completed an inspection of Cargille-Sacher Laboratories Inc. on Apr 16, 2009 in Cedar Grove, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 16, 2009
Fiscal Year
2009
Product Type
Devices
Project Area
Compliance: Devices
Location
Cedar Grove, NJ (United States)

Citations

IDCFRDescription
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
326321 CFR 820.250(b)Sampling plans
366921 CFR 820.20(c)Management review - defined interval, sufficient frequency
421221 CFR 806.20(b)(4)Justification for not reporting

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.